ConductScience.org, home

Gene · 3205

NIH grants2,818

NIH grants whose papers are about the gene, through NIH's grant-paper links.

121 to 140 of 2,818

Download this page as JSON
GrantTitleHOXA9 papersNewest fiscal year
R01AI091627Notch Signaling in Alloimmunity22025
R01AI118891Viral modulation of epitranscriptomic mechanisms22025
R01CA132946Genomics of AML Prognosis22025
R01CA183252DNMT3A in Development of Hematologic Malignancies22025
R01CA252707Molecular analysis of ASH1L22025
R01CA258904Investigating novel synthetic lethal epigenetic interactions in Acute Myeloid Leukemia22025
R01CA259480MEF2D-Mediated Transcriptional Control of Acute Myeloid Leukemia22025
R01CA266057Novel Small-Molecule Probes Targeting Oncogenic Fusion MLL in Pediatric Leukemia22025
R01DK103794Systematic Genetic Dissection of Human Erythropoiesis22025
R01HG006827Labeling and sequencing of 5hmC and 5mC in DNA-Renewal22025
R01HG009299Title: Functional Annotation of Genomes via Phenotypic Convergence within Large Multi-species Alignments22025
R24GM137786IDeA National Resource for Quantitative Proteomics22025
R25CA174664Integrative Molecular Epidemiology Workshop22025
R35CA197594Synergistic role of signaling and epigenetics in leukemic transformation22025
R35CA197699Molecular strategies for early detection and targeting of cancer22025
R35GM128645Mechanisms and impacts of chromatin looping22025
R50CA211404Therapeutic insights through patient derived leukemia xenografts22025
T32AG000181Training in the Epidemiology of Aging22025
T32CA009302Leveraging innovative technologies in basic and clinical cancer research22025
T32CA009523Contemporary Approaches to Cancer Cell Signaling and Communication22025

Source NIH's project filesgene-search-2026-11-11-0.2.0

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/genes/v1/3205/grants?page=7